by Truveta staff | Oct 29, 2025 | News
Today, Truveta was featured as #1 on LinkedIn’s Top Startups in Seattle for 2025 list. The ranking highlights ten growing start-up companies in the Seattle area. Last year, Truveta was ranked #3 on the inaugural Seattle list. Earlier this month, Truveta was also...
by Truveta staff | Oct 3, 2025 | News
The US Food and Drug Administration (FDA) recently published a comprehensive overview of how real-world evidence (RWE) has contributed to regulatory decision-making since 2011. The new webpage, built by the Center for Drug Evaluation and Research (CDER) and the Center...
by Truveta staff | Sep 23, 2025 | News
Medical device manufacturers and regulators face a persistent challenge: obtaining a complete, clinically rich view of how devices are used, how safe they are, and how they affect patient outcomes. Historically, researchers have been limited to claims, chargemaster,...
by Terry Myerson, CEO | Sep 22, 2025 | News
Today marks the 5 year anniversary of Truveta. I personally am so humbled by where we are today. As I reflect back to where we were in 2020, the world was a very different place. It was a time of great uncertainty. The world was desperate for answers to a pandemic...
by Truveta staff | Sep 10, 2025 | News
At Johns Hopkins University, the Hopkins Business of Health Initiative (HBHI) has launched the HBHI–Truveta User Community, dedicated to fostering a collaborative group of researchers who use Truveta Data to drive cutting-edge research in health and healthcare. Led by...
by Sujatha Sagiraju | May 22, 2025 | News
As machine learning models increasingly assist in interpreting patient records, understanding how to properly evaluate these models becomes crucial for ensuring reliable clinical research outcomes. Jay Nanduri, Truveta CTO, provided an overview of Truveta language...
